发明名称 |
METHODS OF DETERMINING WHETHER THE WNT SIGNALING PATHWAY IS UPREGULATED IN A TUMOR |
摘要 |
The invention demonstrates that canonical Wnt signaling is activated in certain primary tumors and tumor cell lines in the absence of ?-catenin or APC mutations and that inhibition of such activated canonical Wnt signaling in such tumor cells inhibits tumor growth and, at least in some cases, induces death of tumor cells. As further demonstrated herein, the activation of canonical Wnt signaling is associated with a higher rate of cancer recurrence in patients with Stage I Non-Small Cell Lung Cancer (NSCLC), which provides a new method for cancer prognosis, wherein activation of canonical Wnt signaling reflects a more aggressive tumor phenotype suggesting the need for a more aggressive therapy. |
申请公布号 |
US2016274120(A1) |
申请公布日期 |
2016.09.22 |
申请号 |
US201615078644 |
申请日期 |
2016.03.23 |
申请人 |
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
发明人 |
Aaronson Stuart;Akiri Gal;Vijayakumar Sapna |
分类号 |
G01N33/574;C12Q1/68 |
主分类号 |
G01N33/574 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of determining whether a canonical Wnt signaling is activated in a tumor isolated from a subject comprising measuring the amount of uncomplexed β-catenin in the tumor. |
地址 |
New York NY US |